- Home
- MIRM vs LAUR Comparison
MIRM vs LAUR Comparison
Compare MIRM & LAUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRM | LAUR |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.1B |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MIRM | LAUR |
|---|---|---|
| Price | $107.23 | $36.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | ★ $119.85 | $39.63 |
| AVG Volume (30 Days) | 637.7K | ★ 1.1M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $19,138,000.00 | ★ $1,484,288,000.00 |
| Revenue This Year | $26.22 | $14.58 |
| Revenue Next Year | $22.04 | $7.85 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.48 |
| 52 Week Low | $47.89 | $21.53 |
| 52 Week High | $114.99 | $38.28 |
Technical Indicators
Market Signals| Indicator | MIRM | LAUR |
|---|---|---|
| Relative Strength Index (RSI) | 64.97 | 62.36 |
| Support Level | $87.93 | $33.10 |
| Resistance Level | $107.51 | $37.91 |
| Average True Range (ATR) | 4.13 | 1.16 |
| MACD | 1.17 | 0.19 |
| Stochastic Oscillator | 96.61 | 71.23 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About LAUR Laureate Education Inc.
Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its reportable segments include Peru and Mexico, of which Mexico derives maximum revenue. Geographically, the company operates in Mexico, Peru and United States.